Daniel Corey

Daniel Corey

Vorstandsvorsitzender bei CERo Therapeutics, Inc.

Vermögen: 624 467 $ am 31.05.2024

44 Jahre
Consumer Services
Health Technology

Ursprung des Netzwerks ersten Grades von Daniel Corey

EinheitArt der EinheitIndustrie
2
Subsidiary Biotechnology 2

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Daniel Corey

UnternehmenSektorVerknüpfte PersonenHauptposition
Pharmaceuticals: Major

Brian Atwood

Chief Executive Officer

Miscellaneous Commercial Services

Michael Byrnes

Comptroller/Controller/Auditor

EXELIXIS, INC. Pharmaceuticals: Major

Michael Morrissey

Chief Executive Officer

Miscellaneous Commercial Services

Michael Byrnes

Director of Finance/CFO

Versant Ventures I LLC

Brian Atwood

Founder

Versant Venture Capital III LP Investment Managers

Brian Atwood

Corporate Officer/Principal

Versant Ventures II LLC

Brian Atwood

Corporate Officer/Principal

Miscellaneous Commercial Services

Brian Atwood

Director/Board Member

VERACYTE, INC. Medical Specialties

Brian Atwood

Chairman

PRINCIPIA BIOPHARMA INC. Pharmaceuticals: Major

Michael Byrnes

Director of Finance/CFO

ATRECA, INC. Biotechnology

Brian Atwood

Lindsey Rolfe

Chairman

Director/Board Member

Biotechnology

Michael Byrnes

Director of Finance/CFO

Investment Managers

Brian Atwood

Private Equity Investor

College/University

Michael Morrissey

Doctorate Degree

Miscellaneous Commercial Services

Charles Carter

Corporate Officer/Principal

University of California, Los Angeles College/University

Robyn Rapaport

Masters Business Admin

OCERA THERAPEUTICS INC Pharmaceuticals: Major

Michael Byrnes

Director of Finance/CFO

Investment Managers

Christopher Ehrlich

Corporate Officer/Principal

California State University-East Bay College/University

Michael Byrnes

Masters Business Admin

The University of Edinburgh College/University

Lindsey Rolfe

Doctorate Degree

Santa Clara University College/University

Michael Byrnes

Undergraduate Degree

University of Wisconsin College/University

Michael Morrissey

Undergraduate Degree

University of California, Irvine College/University

Brian Atwood

Undergraduate Degree

Investment Trusts/Mutual Funds

Lawrence Corey

Corporate Officer/Principal

Versant Ventures III LLC

Brian Atwood

Corporate Officer/Principal

The Royal College of Physicians College/University

Lindsey Rolfe

Corporate Officer/Principal

Miscellaneous Commercial Services

Lawrence Corey

President

Biotechnology

Lawrence Corey

Corporate Officer/Principal

Miscellaneous Commercial Services

Lawrence Corey

Corporate Officer/Principal

PHASERX, INC. Pharmaceuticals: Major

Brian Atwood

Director/Board Member

IMMUNE DESIGN CORP Pharmaceuticals: Major

Brian Atwood

Lawrence Corey

Director/Board Member

Founder

Versant Ventures IV LLC

Brian Atwood

Corporate Officer/Principal

CLOVIS ONCOLOGY, INC. Pharmaceuticals: Major

Brian Atwood

Lindsey Rolfe

Director/Board Member

Chief Tech/Sci/R&D Officer

Miscellaneous Commercial Services

Lawrence Corey

Director/Board Member

Medical/Nursing Services

Brian Atwood

Director/Board Member

Harvard Business School College/University

Brian Atwood

Masters Business Admin

Perkin-Elmer Cetus Instruments

Brian Atwood

Founder

Pharmaceuticals: Major

Michael Morrissey

Director/Board Member

Biotechnology

Brian Atwood

Founder

VERA THERAPEUTICS, INC. Biotechnology

Michael Morrissey

Chairman

EFFECTOR THERAPEUTICS, INC. Biotechnology

Christopher Ehrlich

Michael Byrnes

Director/Board Member

Director of Finance/CFO

Cadence Pharmaceuticals , Inc.

Brian Atwood

Director/Board Member

Statistik

International

Vereinigte Staaten 48
Vereinigtes Königreich 3
China 2

Sektoral

Health Technology 20
Consumer Services 10
Commercial Services 9
Finance 6
Miscellaneous 2

Operativ

Director/Board Member 76
Corporate Officer/Principal 31
Independent Dir/Board Member 27
Founder 14
Director of Finance/CFO 13
  1. Börse
  2. Insiders
  3. Daniel Corey
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT